FDA OKs Trial Design of INOpulse Device as Treatment for Pulmonary Hypertension Linked to Lung Disease
News
The U.S. Food and Drug Administration has signed off on the design of a Phase 2b trial of INOpulse, a device that delivers nitric oxide, as a treatment for patients with pulmonary ... Read more